Tear Film Innovations iLux Safety Study
- Conditions
- Evaporative Dry EyeMeibomian Gland Dysfunction
- Interventions
- Device: iLux 2020 System
- Registration Number
- NCT03055897
- Lead Sponsor
- Tear Film Innovations, Inc.
- Brief Summary
The objective of this study was to measure the temperature of the cornea and surrounding eye tissue temperature immediately after heating the eyelids with the iLux device using the protocol treatment profile. Eligible participants attended one treatment visit, with follow-up one day following the procedure.
- Detailed Description
Alcon Research, LLC, acquired TearFilm Innovations, Inc., in December 2018. This study was designed and conducted by TearFilm Innovations, Inc. The study results were collected, analyzed, and provided by TearFilm Innovations, Inc., to Alcon Research, LLC.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
- Sign written informed consent prior to study participation
Key
- History of ocular surgery within 1 year
- Active ocular infection
- Ocular surface abnormality; lid surface abnormalities
- Pregnant, nursing or not utilizing adequate birth control measures
- Other protocol-specified exclusion criteria may apply
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description iLux 2020 System iLux 2020 System Meibomian gland treatment (Day 0) according to instructions for use (IFU)/User Manual
- Primary Outcome Measures
Name Time Method Mean Overall Maximum Temperature of the Cornea and Surrounding Eye Tissue Immediately Post-treatment Day 0 immediately post-treatment Post-heating values were obtained by infrared camera for each participant. The cornea, the eyelid, and the surface tissue surrounding the eye were measured. Both eyes contributed to the analysis. No formal hypothesis testing was specified.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
TearFilm Innovations Investigative Site
🇺🇸Encinitas, California, United States